Brief: Inhibrx Biosciences, Inc Provides Progress Updates On The Inbrx-106 Program And The Expansion Cohorts Of The Ozekibart (Inbrx-109) Program
16/12/2025 22:11
Dec 16 (Reuters) - Inhibrx Biosciences Inc INBX.O: INHIBRX BIOSCIENCES PROVIDES PROGRESS UPDATES ON THE INBRX-106 PROGRAM AND THE EXPANSION COHORTS OF THE OZEKIBART (INBRX-109) PROGRAM Source text: ID:nPn5bqyPVa Further company coverage: INBX.O ((((Reuters.Briefs@thomsonreuters.com;));))
Recent news on Inhibrx Biosciences
See all newsInhibrx's combination cancer drug shrinks tumors in mid-stage head and neck cancer study (updated)
Inhibrx's combination cancer drug shrinks tumors in mid-stage head and neck cancer study
NASDAQ RESUMED AT 08:00 AM
Brief: Inhibrx's Inbrx-106 Nearly Doubles Response Rate And Achieves Interim Median Pfs Of 9.6 Months In Phase 2 Hnscc Study
NASDAQ TRADE HALT HALT NEWS PENDING AT 07:25 AM